Cytura Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
2ndary - Private
- Investors
-
4
Cytura Therapeutics General Information
Description
Developer of small-molecule cancer drugs designed to tackle instabilities in the human genome linked to the spread of cancer. The company's drug will slow down or stop genomic instability and could be applied both as a stand-alone therapy and in combination therapy to overcome resistance or avoid relapse, enabling healthcare providers to improve the lives of patients.
Contact Information
Website
www.cyturatherapeutics.comCorporate Office
- Kloosterstraat 9
- Pivot Park, Life sciences campus for pharmaceutical innovation
- 5349 AB Oss
- Netherlands
Corporate Office
- Kloosterstraat 9
- Pivot Park, Life sciences campus for pharmaceutical innovation
- 5349 AB Oss
- Netherlands
Cytura Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | 30-Jun-2023 | Completed | Generating Revenue | |||
| 1. Seed Round | 23-Apr-2019 | Completed | Generating Revenue |
Cytura Therapeutics Signals
Cytura Therapeutics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Amsterdam UMC Ventures Holding | Venture Capital | Minority | ||
| CD3 Leuven | Venture Capital | Minority | ||
| KU Leuven Research & Development | University | Minority | ||
| Thuja Capital Management | Venture Capital | Minority |
Cytura Therapeutics FAQs
-
When was Cytura Therapeutics founded?
Cytura Therapeutics was founded in 2018.
-
Where is Cytura Therapeutics headquartered?
Cytura Therapeutics is headquartered in Oss, Netherlands.
-
What is the size of Cytura Therapeutics?
Cytura Therapeutics has 4 total employees.
-
What industry is Cytura Therapeutics in?
Cytura Therapeutics’s primary industry is Drug Discovery.
-
Is Cytura Therapeutics a private or public company?
Cytura Therapeutics is a Private company.
-
What is Cytura Therapeutics’s current revenue?
The current revenue for Cytura Therapeutics is .
-
Who are Cytura Therapeutics’s investors?
Amsterdam UMC Ventures Holding, CD3 Leuven, KU Leuven Research & Development, and Thuja Capital Management have invested in Cytura Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process